Site Search

726 results for form to restart a pac on insurance

  1. [pdf] Your guide to Term life insurance
  2. [pdf] Why EquiLiving Critical Illness Insurance
  3. Policy Loan
  4. About
  5. Equitable Life Group Benefits Bulletin - September 2022

    Homewood Health launches Sentio, an upgraded iCBT platform

    Equitable Life’s mental health partner, Homewood Health, has launched Sentio, an upgraded platform for Internet-based cognitive behavioural therapy (iCBT). This self-directed platform is now available to all Equitable Life clients, and it replaces Homewood’s previous iCBT platform, i-Volve.

    Sentio Self-Directed iCBT is a comprehensive digital cognitive behavioural therapy platform. Developed by Homewood’s mental health experts, it is an action-oriented solution for plan members, giving them practical resources and activities to help with their depression, anxiety and overall mental health challenges.
     
    Available as a standalone app, on mobile, tablet and desktop, Sentio contains over 20 unique treatment goals for issues like stress management, improving sleep, managing depressive thoughts, and coping with panic. Users can work through treatment goals in any order, at their own pace. It also includes tools and resources to help plan members build skills and change their thought patterns. 

    Sentio iCBT benefits

    Sentio integrates seamlessly with Homewood Pathfinder so that users can easily locate and take advantage of the iCBT activities available. Sentio also includes a number of unique features:
    • More interactive features and activities to help plan members build valuable mental health skills
    • Integrated symptom measurement and progress tracking
    • Interactive multimedia learning and cognitive exercises to enhance learning
    • Progress, learnings, and exercises that have been accessed are available to be re-accessed for 12 months 
    Access to i-Volve will end 30 days after your clients received access to Sentio, but plan members can complete any in-progress sessions until then.

    Please contact your Group Account Executive or myFlex Sales Manager if you have any questions.
     

    Streamlining disability claims with Opifiny

     Equitable Life is partnering with Opifiny to provide a quicker and more seamless disability claims experience.
     
    Opifiny is an online platform that streamlines the disability claims process for consulting physicians, benefits plan sponsors, and disability plan members. Equitable Life will be using Opifiny for ongoing disability claims management, modernizing the process of gathering medical assessments and information.
     
    Disability claims frequently involve several instances of correspondence between Equitable Life and the plan member’s medical team. By using the secure platform, health care professionals can access, respond to and process medical insurance requests easily from any device. They can typically complete administrative tasks associated with disability claims in a quarter of the time. The platform is secure and protects the privacy of their patients’ confidential information.
     
    By digitizing and modernizing the claims management process for doctors, Equitable Life will have faster access to higher quality claims information. For some claims, using Opifiny may enable Equitable Life to help plan members safely return to work sooner.
     

    Reminder: Obtaining plan member signatures on all administration forms

    Please remind your clients that plan members must sign all administration forms, including enrolment forms, benefits change forms, and beneficiary designation forms. Once completed, a plan administrator can keep the form or send it to us. We are not able to accept a beneficiary designation that has not been signed by the plan member. Having appropriately signed forms helps to ensure that any life insurance claims are paid to the intended recipients.

    For your clients’ convenience, forms can be signed electronically using one of our approved vendors, which include DocuSign, BambooHR, Adobe Sign, and many more.

    If you have questions about providing signed forms, please contact your Group Account Executive or myFlex Sales Manager.
     

    Correction: Coverage for full-time students and dependents with disabilities

    In our August edition of eNews, we provided incorrect information about benefits coverage options for over-age dependents. We indicated that over-age dependents who are full-time students may continue to be eligible under the plan member’s benefits plan if they are studying in their home province. However, attending a post-secondary institution in their home province is not a requirement for continued eligibility. Dependents who are full-time students may continue to be eligible for coverage regardless of where in Canada they are attending post-secondary education.

    If your clients have any questions about extending coverage for over-age dependents that are full-time students, please notify them of this error.
     
    We apologize for any inconvenience or confusion this may have caused.


     
  6. EZstart
  7. Equitable Life Group Benefits Bulletin – September 2021 In this issue: *Indicates content that will be shared with your clients

    Right drug, right dose

    Equitable Life partners with Personalized Prescribing Inc. to help plan members avoid treatment trial and error
     
    Patients suffering from mental health conditions often need to try several medications before they find one that works for them. This is frustrating and can result in negative side-effects, a longer recovery, lost productivity, or a delayed return to work.
     
    To help plan members avoid this treatment trial and error, we have partnered with Personalized Prescribing Inc. to provide easier access to pharmacogenomic testing for plan members with mental health conditions.
     
    Pharmacogenomics 101
    Pharmacogenomics is the study of how an individual’s genes influence their response to medications. Pharmacogenomic testing can help determine how compatible a patient’s body may be to a particular drug, and helps their physician prescribe the most appropriate medication. The goal is to ensure the right drug is prescribed to deliver the most positive outcome with the fewest side effects.
     
    Easier access to pharmacogenomic testing
    Through our partnership with Personalized Prescribing Inc., any Equitable Life plan member diagnosed with a mental health condition can purchase a pharmacogenomic test for a discounted price of $399 plus HST – a 20% savings.
     
    We are also introducing the option for plan sponsors to add coverage of pharmacogenomic tests provided by Personalized Prescribing Inc. for mental health conditions.
     
    With this coverage, plan members are eligible for pharmacogenomic testing if:
    • They have been diagnosed with a mental health condition;
    • They are currently taking or have stopped taking a medication for a mental health condition that does not work or has side effects; and
    • The pharmacogenomic test is conducted by Personalized Prescribing Inc.
    How it works
    Getting a test is easy. The plan member starts by visiting www.personalizedprescribing.com/equitablelife to request a test kit.
     
    Once they receive their test kit from Personalized Prescribing Inc., they simply provide a saliva sample and send it back (postage is pre-paid). Within 7-10 business days, they receive an Rx Report™ that they can share with their doctor. This report includes details to help their doctor prescribe the right drug and the right dose for them.
     
    Benefits for plan members:
    • The plan member and their physician receive a full report that is easy to understand;
    • The report identifies the most compatible medications for the plan member’s condition and the medications to avoid;
    • The physician is able to prescribe the most appropriate medication with the fewest side effects; and
    • The plan member avoids medication trial and error.
    Benefits for employers:
    • Pharmacogenomic testing can be an effective prevention strategy to help employees stay healthy and potentially avoid a mental health-related work absence; and
    • Employees suffering from mental health conditions may be more productive when they are on the right medication for them.
    To learn more about pharmacogenomic testing through Equitable Life and Personalized Prescribing Inc., please visit www.personalizedprescribing.com/equitablelife. To request coverage for your clients, please contact your Equitable Life Group Account Executive or myFlex Sales Manager.

    Responding to New Brunswick’s Biosimilar Initiative

    We are changing coverage for some biologic drugs in New Brunswick in response to the province’s Biosimilar Initiative. These changes will help protect your clients from additional drug costs while still providing access to equally safe and effective biosimilars.
     
    What is New Brunswick’s Biosimilar Initiative?
    New Brunswick’s Biosimilar Initiative will end provincial coverage of several originator biologic drugs for some or all conditions beginning on December 1, 2021. Patients who are using these drugs for the affected conditions will be required to switch to biosimilar versions of the drugs to maintain coverage under the province’s government drug plan.
     
    What is the impact on private drug plans?
    The most significant risk to plan sponsors who maintain coverage of originator biologics is coordination of benefits (CoB) risk. If other insurance carriers follow suit with the province and delist the originator biologics, it could expose a plan that doesn’t delist them to significant coordination of benefits risk.
     
    For example, consider a patient who is covered under two private plans – their employer plan and a spousal plan. If their employer plan was the first payer for the originator biologic but delists the drug, the spousal plan now becomes the first payor. If the spousal plan continues to cover the cost of the originator, it now pays most or all of the cost of the drug.

    How is Equitable Life responding?
    To protect your clients’ plans from paying additional and avoidable drug costs, we are changing coverage in New Brunswick for most biologic drugs included in the provincial initiative.
     
    Beginning Feb. 1, 2022, plan members in New Brunswick will no longer be eligible for coverage of Humira, Lantus, Humalog and Copaxone if they have a condition for which Health Canada has approved a lower cost biosimilar version of the drug. These plan members will be required to switch to a biosimilar version of those drugs to maintain coverage under their Equitable Life plan.
     
    How will Equitable Life communicate this change to plan members?
    We will be communicating with affected claimants in early-December 2021 to allow them ample time to change their prescriptions and avoid any interruptions in their treatment or their coverage.
     
    Can my client maintain coverage of these biologic drugs?
    All groups, except myFlex clients, who wish to opt out of this change and maintain coverage of these originator biologics for New Brunswick plan members can submit a policy amendment. Amendments must be submitted no later than Nov. 30, 2021.
     
    Advisors with myFlex Benefits clients who wish to maintain coverage of these originator biologics for New Brunswick plan members should speak to their myFlex Sales Manager to confirm their eligibility to opt out of this change.
     
    Groups that opt out of this change are also opting out of any future changes to our New Brunswick biosimilar initiative. Their drug plans will continue to cover any additional originator biologics that we subsequently add to the program.  
     
    Will this change impact my clients’ rates?
    The rate impact of this change and  any cost savings associated with the change will be factored in at renewal.
     
    If plan sponsors opt out of these changes and maintain coverage for the originator biologics, it may result in a rate increase. Any rate adjustment will be applied at renewal.
     
    What is the difference between biologics and biosimilars?
    Biologics are drugs that are engineered using living organisms like yeast and bacteria. The first version of a biologic developed is also known as the “originator” biologic. Biosimilars are also biologics. They are highly similar to the originator drug they are based on and have been shown to have no clinically meaningful differences in safety or efficacy.
     
    Questions?
    If you have any questions about this change, please contact your Group Account Executive or myFlex Sales Manager.
     

    Helping plan members access our convenient digital options

    Some of your clients’ plan members aren’t benefitting from our secure and convenient digital options to access and use their Group Benefits. They can sign up to submit claims electronically for faster claim payments, get claim payments deposited directly to their bank accounts, easily review their coverage details, quickly access their Group Benefits plan booklet, benefits card and more. We’ve made it easier than ever to sign up, with more resources all conveniently located at Equitable.ca/go/digital.

    Your clients’ plan members can visit this link to view:
    • A brochure with all the high-level instructions they need to get started on EquitableHealth.ca and the EZClaim mobile app
    • A full video guide on how to access and navigate EquitableHealth.ca
    If your clients’ plan members need help activating these services, they can give us a call at 1-800-265-4556 and select the option for web support. We’d be happy to help!
     

    Reminder: Please access forms on EquitableHealth.ca*

    We routinely update our Plan Administrator forms on EquitableHealth.ca based on their feedback and to stay compliant with legal and/or regulatory requirements. If your clients need a form, they should always pull the most recent version from EquitableHealth.ca instead of reusing forms they have saved on their computer. Using an old or outdated form may result in processing delays.
     
    Your clients can access the Plan Administrator forms by following these steps:
    • Login to EquitableHealth.ca
    • Select “Documents”
    • Toggle between English and French forms
    • Click on the document name to download a PDF copy

    Over-age dependents losing coverage?*

    Some of your clients’ plan members may have dependents who are reaching the maximum age for eligibility under their group benefits plan.
     
    If they are attending school full-time or are disabled, they may be eligible for continued coverage. Plan members with over-age dependents can simply complete the Application for Coverage of Dependent Child Over Age 21 (Form #441) and submit it through our online document submission tool. They can access the tool by logging into their Group Benefits account at www.equitablehealth.ca and clicking My Resources. 

    If they are not attending school full-time or disabled, they will no longer be covered under the plan. However, they may be eligible for Coverage2go®. It allows individuals who are losing their group coverage to purchase personal month-to-month health and dental coverage that is affordable, reliable and works like their previous group benefits plan. They can choose the level of coverage and protection that suits their personal situation.

    There are no medical questions – they simply need to apply within 60 days of losing their health coverage under their group benefits plan.*
     
    Help your clients’ plan members and their dependents who are losing coverage by letting them know about Coverage2go. They can visit our website to learn more about Coverage2go and to get a quote.
      
    *Quebec residents are not eligible for Coverage2go
  8. [pdf] Gradual Inheritance Strategy
  9. [pdf] Alternative Identification Requirements
  10. [pdf] Agency Application For Contract